SI0977575T1 - The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes - Google Patents

The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes

Info

Publication number
SI0977575T1
SI0977575T1 SI9830312T SI9830312T SI0977575T1 SI 0977575 T1 SI0977575 T1 SI 0977575T1 SI 9830312 T SI9830312 T SI 9830312T SI 9830312 T SI9830312 T SI 9830312T SI 0977575 T1 SI0977575 T1 SI 0977575T1
Authority
SI
Slovenia
Prior art keywords
tyrosine
alpha
methyl
melanin production
inhibit melanin
Prior art date
Application number
SI9830312T
Other languages
English (en)
Slovenian (sl)
Inventor
Filippo Drago
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of SI0977575T1 publication Critical patent/SI0977575T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI9830312T 1997-04-22 1998-04-21 The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes SI0977575T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI000939A IT1291633B1 (it) 1997-04-22 1997-04-22 Uso dell'alfa-metil-p-tirosina per inibire la produzione di melanina nei melanociti dell'iride
PCT/EP1998/002365 WO1998047515A1 (en) 1997-04-22 1998-04-21 THE USE OF α-METHYL-P-TYROSINE TO INHIBIT MELANIN PRODUCTION IN IRIS MELANOCYTES

Publications (1)

Publication Number Publication Date
SI0977575T1 true SI0977575T1 (en) 2003-04-30

Family

ID=11376994

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830312T SI0977575T1 (en) 1997-04-22 1998-04-21 The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes

Country Status (22)

Country Link
US (1) US6359001B1 (enrdf_load_stackoverflow)
EP (1) EP0977575B1 (enrdf_load_stackoverflow)
JP (1) JP2001521540A (enrdf_load_stackoverflow)
KR (1) KR20010020202A (enrdf_load_stackoverflow)
CN (1) CN1255064A (enrdf_load_stackoverflow)
AT (1) ATE227577T1 (enrdf_load_stackoverflow)
AU (1) AU732046B2 (enrdf_load_stackoverflow)
CA (1) CA2287887A1 (enrdf_load_stackoverflow)
DE (1) DE69809408T2 (enrdf_load_stackoverflow)
DK (1) DK0977575T3 (enrdf_load_stackoverflow)
ES (1) ES2187028T3 (enrdf_load_stackoverflow)
HU (1) HUP0002100A3 (enrdf_load_stackoverflow)
IL (1) IL132503A (enrdf_load_stackoverflow)
IT (1) IT1291633B1 (enrdf_load_stackoverflow)
NO (1) NO995122L (enrdf_load_stackoverflow)
NZ (1) NZ500435A (enrdf_load_stackoverflow)
PL (1) PL189304B1 (enrdf_load_stackoverflow)
PT (1) PT977575E (enrdf_load_stackoverflow)
RU (1) RU2218159C2 (enrdf_load_stackoverflow)
SI (1) SI0977575T1 (enrdf_load_stackoverflow)
SK (1) SK284255B6 (enrdf_load_stackoverflow)
WO (1) WO1998047515A1 (enrdf_load_stackoverflow)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60015508T2 (de) 1999-03-05 2005-04-21 Univ Durham C-16 ungesätigte fp-selektive prostaglandin analoge
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
WO2010087983A1 (en) * 2009-01-29 2010-08-05 Kambiz Thomas Moazed Method and system for effecting changes in pigmented tissue
US9744237B2 (en) * 2009-01-29 2017-08-29 Kambiz Thomas Moazed Method and system for effecting changes in pigmented tissue
WO2011011065A1 (en) * 2009-07-22 2011-01-27 Kambiz Thomas Moazed Method and system for effecting changes in pigmented tissue
US10272068B2 (en) 2012-01-17 2019-04-30 Tyme, Inc. Pharmaceutical compositions and methods
JP6276707B2 (ja) * 2012-01-17 2018-02-07 タイム,インコーポレーテッド 薬学的組成物及び方法
US8481498B1 (en) 2012-01-17 2013-07-09 Steven Hoffman Pharmaceutical compositions and methods
US10646552B2 (en) 2012-01-17 2020-05-12 Tyme, Inc. Pharmaceutical compositions and methods
US20130183263A1 (en) 2012-01-17 2013-07-18 Steven Hoffman Pharmaceutical compositions and methods
US10813901B2 (en) 2013-10-22 2020-10-27 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US9326962B2 (en) 2013-10-22 2016-05-03 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US9763903B2 (en) 2013-10-22 2017-09-19 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US9585841B2 (en) 2013-10-22 2017-03-07 Tyme, Inc. Tyrosine derivatives and compositions comprising them
US10751313B2 (en) 2013-10-22 2020-08-25 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
ES2738248B2 (es) * 2018-06-21 2023-03-10 Consejo Superior Investigacion Uso de inhibidores de la tirosina hidroxilasa para el tratamiento del aneurisma de aorta
WO2020018291A1 (en) 2018-07-19 2020-01-23 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
PH12021552866A1 (en) 2019-05-14 2022-11-07 Tyme Inc Compositions and methods for treating cancer
CN116035151A (zh) * 2023-01-18 2023-05-02 云南贝泰妮生物科技集团股份有限公司 一种刺梨闪释粉及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04117313A (ja) * 1990-09-06 1992-04-17 Kanebo Ltd 美白化粧料

Also Published As

Publication number Publication date
SK284255B6 (sk) 2004-12-01
DK0977575T3 (da) 2003-03-10
PT977575E (pt) 2003-03-31
US6359001B1 (en) 2002-03-19
KR20010020202A (ko) 2001-03-15
PL336386A1 (en) 2000-06-19
IL132503A (en) 2004-06-20
ITMI970939A1 (it) 1998-10-22
EP0977575A1 (en) 2000-02-09
IL132503A0 (en) 2001-03-19
ATE227577T1 (de) 2002-11-15
ES2187028T3 (es) 2003-05-16
DE69809408T2 (de) 2003-07-10
NO995122L (no) 1999-12-21
DE69809408D1 (de) 2002-12-19
CA2287887A1 (en) 1998-10-29
HUP0002100A2 (hu) 2000-11-28
CN1255064A (zh) 2000-05-31
AU7646298A (en) 1998-11-13
NZ500435A (en) 2001-09-28
WO1998047515A1 (en) 1998-10-29
ITMI970939A0 (enrdf_load_stackoverflow) 1997-04-22
PL189304B1 (pl) 2005-07-29
SK142499A3 (en) 2000-09-12
EP0977575B1 (en) 2002-11-13
HUP0002100A3 (en) 2003-05-28
RU2218159C2 (ru) 2003-12-10
AU732046B2 (en) 2001-04-12
JP2001521540A (ja) 2001-11-06
IT1291633B1 (it) 1999-01-11
NO995122D0 (no) 1999-10-21

Similar Documents

Publication Publication Date Title
SI0977575T1 (en) The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
DK0925022T3 (da) Forbedringer med relation til hudprikkenåle
ZA952031B (en) Inhibition of hair growth
EP0761173A3 (en) Needle for the administration of therapeutic solutions in the subarachnoid space
ID28947A (id) Metode untuk meringankan inkontinensia uriner wanita
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
ZA978015B (en) Tetrahydronaphthalene derivatives and their therapeutic use
EP0698203A4 (en) METHOD FOR SELECTIVELY OPENING THE CAPILLARIES OF ABNORMAL BRAIN TISSUES
SI0839532T1 (en) Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene
IL150125A0 (en) Novel compounds
ZA200005413B (en) Cholesterol sulfate compositions for enhancement of stratum corneum function.
GB2243546B (en) Improvements in or relating to shower cubicles
EP0971725A4 (en) METHOD FOR TREATING SCAR TISSUE
GEP20043231B (en) Resorcinol Composition
CA2256348A1 (en) Method of improving skin condition
IL116733A0 (en) The use of sertraline to treat cancer patients
DE69700050D1 (de) Verwendung von Octopirox als Hautdepigmentierungsmittel
IT1303729B1 (it) Dispositivo massaggiatore da inserire all'interno di uno schienale dipoltrone di massaggio o simili, dotato di possibilita' di regolazione
EP1322274A4 (en) LOCAL THERAPEUTIC SOLUTION FOR SKIN, AND METHODS OF USE
AU118002S (en) Bathing towel/garment
FR2637497B1 (fr) Installation de massage corporel par hydrotherapie notamment
DE50006414D1 (de) Mistelextrakte in hautkosmetika
BR9302550A (pt) Modelo de cripto-sistema de chave pública
ID17905A (id) Mempernis ulang goresan-goresan pada tutup lingkaran yang mudah dibuka
IT8614909V0 (it) Pannelli doppi-faccia per pubblici ta'fissa ed affissione manifesti, da agganciare ai pali della pubblica illuminazione